| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |